Specific immunotherapy for allergic rhinitis in Italy: The patients' points of view

M. Larosa, G. Ciprandi, C. F. Tesi, G. Cadario, A. Fiocchi, F. Frati, A. Romano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its use is quite limited. A perspective, cross-sectional telephone interview survey was carried out in Italy to evaluate the characteristics of 500 patients with allergic rhinitis (250 of whom treated with SIT). Relevant differences were found concerning therapeutic management of allergic rhinitis, mainly regarding the use of drugs and co-morbidities. The allergist is the most important consultant who prescribes SIT. This study therefore provides evidence that the course of allergic rhinitis may depend on the therapy prescribed by and the level of allergy awareness of the physician.

Original languageEnglish
Pages (from-to)247-250
Number of pages4
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number1
Publication statusPublished - Jan 2009

Fingerprint

Immunotherapy
Italy
Hypersensitivity
Consultants
Therapeutics
Interviews
Morbidity
Physicians
Pharmaceutical Preparations
Allergic Rhinitis
Allergists
Surveys and Questionnaires

Keywords

  • Allergic rhinitis
  • Doctors
  • Educational level
  • Patients
  • Prescription
  • Specific immunotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Specific immunotherapy for allergic rhinitis in Italy : The patients' points of view. / Larosa, M.; Ciprandi, G.; Tesi, C. F.; Cadario, G.; Fiocchi, A.; Frati, F.; Romano, A.

In: International Journal of Immunopathology and Pharmacology, Vol. 22, No. 1, 01.2009, p. 247-250.

Research output: Contribution to journalArticle

@article{2925ab19c327451dad8d44b58bf1ee44,
title = "Specific immunotherapy for allergic rhinitis in Italy: The patients' points of view",
abstract = "Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its use is quite limited. A perspective, cross-sectional telephone interview survey was carried out in Italy to evaluate the characteristics of 500 patients with allergic rhinitis (250 of whom treated with SIT). Relevant differences were found concerning therapeutic management of allergic rhinitis, mainly regarding the use of drugs and co-morbidities. The allergist is the most important consultant who prescribes SIT. This study therefore provides evidence that the course of allergic rhinitis may depend on the therapy prescribed by and the level of allergy awareness of the physician.",
keywords = "Allergic rhinitis, Doctors, Educational level, Patients, Prescription, Specific immunotherapy",
author = "M. Larosa and G. Ciprandi and Tesi, {C. F.} and G. Cadario and A. Fiocchi and F. Frati and A. Romano",
year = "2009",
month = "1",
language = "English",
volume = "22",
pages = "247--250",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "1",

}

TY - JOUR

T1 - Specific immunotherapy for allergic rhinitis in Italy

T2 - The patients' points of view

AU - Larosa, M.

AU - Ciprandi, G.

AU - Tesi, C. F.

AU - Cadario, G.

AU - Fiocchi, A.

AU - Frati, F.

AU - Romano, A.

PY - 2009/1

Y1 - 2009/1

N2 - Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its use is quite limited. A perspective, cross-sectional telephone interview survey was carried out in Italy to evaluate the characteristics of 500 patients with allergic rhinitis (250 of whom treated with SIT). Relevant differences were found concerning therapeutic management of allergic rhinitis, mainly regarding the use of drugs and co-morbidities. The allergist is the most important consultant who prescribes SIT. This study therefore provides evidence that the course of allergic rhinitis may depend on the therapy prescribed by and the level of allergy awareness of the physician.

AB - Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its use is quite limited. A perspective, cross-sectional telephone interview survey was carried out in Italy to evaluate the characteristics of 500 patients with allergic rhinitis (250 of whom treated with SIT). Relevant differences were found concerning therapeutic management of allergic rhinitis, mainly regarding the use of drugs and co-morbidities. The allergist is the most important consultant who prescribes SIT. This study therefore provides evidence that the course of allergic rhinitis may depend on the therapy prescribed by and the level of allergy awareness of the physician.

KW - Allergic rhinitis

KW - Doctors

KW - Educational level

KW - Patients

KW - Prescription

KW - Specific immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=62649123350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649123350&partnerID=8YFLogxK

M3 - Article

C2 - 19309574

AN - SCOPUS:62649123350

VL - 22

SP - 247

EP - 250

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 1

ER -